Gene-Edited Beagles Could End Dog Allergies Forever

Matt Walker spent his entire life wanting a dog but couldn't get near one without suffering allergic reactions. Now he's playing fetch with Bailey, a beagle puppy engineered to be hypoallergenic, in his own backyard.

Walker, a geneticist and CEO of Kindred Companion Sciences, used CRISPR technology to create Alfie and Bailey, the world's first gene-edited hypoallergenic dogs. The puppies, born in September 2024, lack the protein Can f 1 that triggers allergies in roughly one in eight Americans.

The process sounds like science fiction but works through careful steps. Walker's team took skin cells from a beagle, edited out the allergen gene, and cloned those modified cells into donor eggs. A surrogate beagle carried 25 reconstructed embryos and delivered the two healthy pups.

Tests confirmed the breakthrough worked. Researchers found no traces of Can f 1 in Alfie and Bailey's saliva or dander, while regular beagles and even supposedly hypoallergenic breeds like poodles and goldendoodles still carried the protein.

Walker brought the ultimate test home. Skin-prick allergy testing showed he reacted to samples from regular dogs but had zero reaction to dander and saliva from Alfie and Bailey. After decades of keeping his distance, he finally lives with the companion he always wanted.

The Ripple Effect

This breakthrough could transform life for millions of allergy sufferers who've watched friends enjoy dog ownership from afar. Bailey and Alfie represent just the beginning of what Walker calls "the next generation of companion animals."

The team plans to create founder animals that breed naturally and pass the hypoallergenic trait to their puppies. Every pup from two edited parents would inherit the allergen-free genes, potentially creating an entire generation of dogs that won't trigger sniffles.

Some bioethicists worry the technology might discourage adoption of shelter animals. Others point out this isn't much different from centuries of selective breeding, just faster and more precise. Arthur Caplan, a bioethicist at NYU, believes it opens doors for countless people to experience the joy of pet ownership.

The dogs won't hit the market soon since the FDA hasn't approved the genetic modification yet. The edit also won't help everyone, as other proteins like Can f 2 can trigger allergies too.

Both puppies remain healthy and active, though Walker's team monitors them closely. Alfie lives with another researcher while Bailey enjoys life with her creator, finally making his childhood dream come true.